PARP-i Qualitative Study
About the project: Qualitative exploration of PARP-i long term users in advanced ovarian cancer
Who can take part
We are seeking people living with recurrent ovarian cancer who are long term users of PARP inhibitors – that is, either:
· Used PARP-I for >5 years and ceased treatment for reasons other than disease progression; or,
· Have been using PARP-I for >5 years with ongoing benefit
Participants must be over 18 years of age and able to speak and read English adequately to participate in a semi-structured interview.
What participation involves
Taking part in this project will involve participation in a semi-structured interview via zoom for approximately 45 minutes. All responses will be kept confidential.
Contact details
If you have any questions about this project, please contact:
Prof. Haryana Dhillon
Phone +61 2 9036 5392
Email: Haryana.dhillon@sydney.edu.au
A/Prof Yeh Chen Lee
Phone: +61 2 9382 5111
Email: yehchen.lee@health.nsw.gov.au
How to participate
To take part in this project, please click the following link:
https://qualtricsxm2l94gysd4.qualtrics.com/jfe/form/SV_9ojmnoHaSkoJj4W
Ethics approval
This project has been approved by the University of Sydney Human Research Ethics Committee (HREC) [2025/HE001461].
We are conducting a research project about the experiences of people with recurrent ovarian cancer who have responded to PARP-inhibitor therapy for an extended period of time. For this cohort of people, it is unclear how long therapy should be continued, particularly due to some concerns about long term side effects.
We want to explore the experiences of consumers around choosing to stop or continue PARP-inhibitor therapy and influences and supports in doing so.
